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Autophagyas undertaken to measure the relative abilities of pro-death versus pro-survival
proteases in degrading each other and to determine how this might inﬂuence cellular susceptibility to death.
For this, we ﬁrst carried out in vitro experiments in which recombinant pro-death proteases (caspase-3 or
cathepsin D) were incubated with the pro-survival protease (cathepsin L) in their respective optimal
conditions and determined the effects of these reactions on enzyme integrity and activity. The results
indicated that cathepsin L was able to degrade cathepsin D, which in turn cleaves caspase-3, however the
later enzyme was unable to degrade any of the cathepsins. The consequences of this proteolytic sequence on
cellular ability to undergo apoptosis or other types of cell death were studied in cells subjected to treatment
with a speciﬁc inhibitor of cathepsin L or the corresponding siRNA. Both treatments resulted in suppression
of cellular proliferation and the induction of a cell death with no detectable caspase-3 activation or DNA
fragmentation, however, it was associated with increased accumulation of cathepsin D, cellular vaculoliza-
tion, expression of the mannose-6-phosphate receptor, and the autophagy marker LC3-II, all of which are
believed to be associated with autophagy. Genetic manipulations leading either to the gain or loss of
cathepsin D expression implicated this enzyme as a key player in the switch from apoptosis to autophagy.
Overall, these ﬁndings suggest that a hierarchy between pro-survival and pro-death proteases may have
important consequences on cell fate.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Protein degradation is as important for cellular viability as their
synthesis and proteases have long been considered as guardians of
cellular homeostasis. A number of key cellular functions are controlled
by different proteases such as the execution of cell death mediated by
caspases [1], degradation and elimination of abnormal proteins by
cathepsins or proteasome [2], and cancer metastasis facilitated by
metalloproteases and cathepsins [3]. Due to their protein nature, it is
likely that enzymes from one group may exhibit cleavage sites for
proteases from another group. Consequently, cellular functions that
are directly controlled by the ﬁrst group of proteases would be
indirectly governed by the second one. It has been shown for instance
that cathepsin D can cleave and activate the pro-apoptotic molecule
Bid, which in turn causes cytochrome c release and the activation of
caspase-3 [4]. Based on this, cathepsin D may be considered as a pro-
apoptotic molecule although it has been recently shown that this
enzyme may also signal for a non-apoptotic cell death [5]. In contrast
to the pro-apoptotic proteases caspase-3 and cathepsin D, cathepsin L1 518 694 7567.
l rights reserved.was reported to play a protective role against stress-mediated cell
death [6]. An example for this was provided by previous work
demonstrating that this enzyme attenuates cellular susceptibility to
apoptosis by degrading cathepsin D [7]. The role of cathepsin L in cell
survival was demonstrated in C. elegans in which transfection with
siRNAs to this enzyme resulted in embryonic lethality [8]. Although
the loss of cathepsin L expression was not lethal in mice, it was
associated with severe abnormalities in the heart, brain, and skin
[9–12], suggesting that this enzyme may be required for cell survival
and normal organ development. In agreement with this concept, we
have reported that cathepsin L protects cancer cells from the cytotoxic
effect of chemotherapeutic agents and its inhibition reverses drug
resistance in various cancer cell lines [13]. Findings from this study
indicated that that cathepsin L protects cancer cells not only against
drug induced apoptosis but also against irreversible growth arrest,
termed senescence [13], suggesting that targeting this molecule may
hold great promise for therapeutic interventions against cancer.
The possibility that pro-death and pro-survival proteases may
coexist and interact within the same cellular compartment raises the
possibility that they will regulate the function of each other. As a
result, cellular physiological functions and particularly its suscep-
tibility to death will be signiﬁcantly altered. The present study was
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response that may result from disruption of protease hierarchy.
2. Material and methods
Human neuroblastoma SKN-SH, osteosarcoma SaOS2 and prostate
cancer LNCap cells were purchased from ATCC (Rockville MA).
Dulbecco's Modiﬁed Eagle's Medium (DMEM) and fetal bovine
serum (FBS) were obtained from BioWhittaker (Walkersville, MD).
The following drugs and reagents were obtained from the companies
cited: recombinant cathepsin L, cathepsin D and caspase 3 from R&D
Systems (Minneapolis, MN), cathepsin L inhibitor Napsul-Ile-Trp-CHO
(iCL) from Biomol (Playmouth Meeting, PA); the autophagosome
inhibitor 3-MA and doxorubicin (Sigma, St. Louis, MO); Antibody to
cathepsin L (Novus Biologicals, Littleton, CO); cathepsin D (Abcam,
Cambridge, MA); active caspase-3 (Cell signaling Technology, Beverly,
MA), p21/WAF1, LC3-II (Santa Cruz Biotechnologies, Santa Cruz, CA)
and MPR (Abcam, Cambridge, MA); reagents for siRNA transfection
from (Gene Therapy Systems, San Diego, CA), antibody to beta-Actin
from Sigma (St. Louis, MO); secondary antibodies conjugated to
horseradish peroxidase from BioRad (Hercules, CA); Enhanced
chemiluminescence reagents (ECL) from Amersham (Arlington
Heights, IL); immobilon-P transfer membrane for Western blots from
Millipore (Bedford, MA).
2.1. Cleavage reactions
Cleavage of recombinant cathepsin D and caspase-3 by puriﬁed
cathepsin L was performed by incubating various amounts of the
latter enzyme (1 to 5 ng) with 100 ng of the substrates (cathepsin D
and caspase-3) in reaction buffer (100 mM sodium acetate pH 5, 1 mM
EDTA, and 4 mM dithiothreitol). Similar procedure was undertaken to
study the cleavage of cathepsin L and caspase-3 by cathepsin D in
100 mM sodium acetate, pH 3. The cleavage of both cathepsins by
caspase-3 was carried out in a reaction buffer (100 mM HEPES, 20%
(v/v) glycerol, 0.5 mMEDTA, 5mMDTT). After incubation for 20min at
room temperature, Proteins were denatured by boiling, separated by
SDS-PAGE and transferred to Immobilon P membrane. Speciﬁc
antibodies were used to detect each one of these enzymes.
2.2. Protease activity assays
Cathepsin L activity was measured as described previously [13].
Brieﬂy, the puriﬁed enzyme (200 ng) was incubated in a 96-well
plate for 15 min at room temperature in 100 μl of reaction buffer
[100 mM sodium acetate (pH 5), 1 mM EDTA, and 4 mM DTT]. One
hundred μl of substrate were added and incubated for an additional
30 min at room temperature. Fluorescence was measured in a plate
reader (Victor Multilabel Counter; Perkin-Elmer) at 380-nm excita-
tion and 450-nm emission wavelengths. Cathepsin D activity was
measured using the assay kit #143-100 (Biovision, Mountain View,
CA) as described by the manufacturer. The activity of caspase-3 was
assayed using the caspase-speciﬁc ﬂuorescence peptide substrates
Ac-DEVD-AFC (Biomol Playmouth Meeting, PA) according to the
manufacturer's instructions. Relative enzymatic activitieswere obtained
by comparing those of enzymes incubated in reaction buffer alone to
those in the presence of other proteases.
2.3. Western blot
Cells were seeded in DMEM containing 10% FBS, and after 24 h,
increasing amounts of iCL were added to the culture medium and
incubated for an additional 24 h. Western blots were carried out as
described earlier [22]. Proteins of interest were identiﬁed by reaction
with speciﬁc primary and secondary antibodies linked to horseradish
peroxidase and detected by chemiluminescence.2.4. Electron and ﬂuorescence microscopy
Cells were seeded in 75 cm2 ﬂaks and incubated for 24 h at 37 °C
then subjected to treatment with iCL for an additional 24 h. For
electron microscopy, the cells were were trypsinized and washed
three times with cold PBS, ﬁxed in 2% osmium tetroxide in 0.1 M
cacodylate buffer, pH 7.4, and dehydrated and embedded in epon.
Thin sections were cut and following lead to citrate and uranyl-
acetate contrasting, the cells were observed under electron micro-
scope and photographs taken. For ﬂuorescent microscopy, the cells
were ﬁxed with paraformaldehyde 4% for 5 min and after washing,
they were incubated with antibodies against LC3-II at 4 °C for 15 h.
After wash with PBS, the cells were then incubated for 1 h at 4 °C with
ﬂuorescence labeled secondary antibodies and pictured under
ﬂuorescence microscopy.
2.5. DNA fragmentation
Cells were incubated with iCL at various concentrations for 24 h at
37 °C and DNA prepared from Triton X-100 lysates for analysis of
fragmentation. Brieﬂy, cells were lysed in a hypotonic solution
containing 10 mM Tris–HCl (pH 7.4), 1 mM EDTA, and 0.2% Triton
X-100, and centrifuged at 11000 ×g for 5 min. Supernatants were
electrophoresed on a 1% agarose gel and DNA fragments visualized
under UV light after staining with ethidium bromide.
2.6. APO-BRDU assay for apoptosis
SaOS2 cells (1×106) were plated in 100 mm dishes and allowed to
adhere for 24 h. Cells were treated with the appropriate concentra-
tions of cathepsin L inhibitor. After 24 h, the cells were harvested in
PBS and ﬁxed in 1% paraformaldehyde. After two washes in PBS, cells
were re-suspended in ethanol and stored at −20 °C until further
analysis. Percentage apoptosis was determined using the APO-BRDU
assay kit from BD Biosciences (CA, USA). In this assay, the cell pellet
was incubated with brominated deoxyuridine triphosphate (BRDU)
and TdT (terminal deoxynucleotidyl transferase) enzyme for 24 h at
28 °C. BRDU incorporated into the 3′-hydroxyl termini of double- and
single-stranded DNA was identiﬁed by staining the cells with a
ﬂuorescent labeled anti-BRDU monoclonal antibody, using ﬂow
cytometry.
2.7. siRNA design and transfections
The Human cathepsin D and cathepsin L siRNAs [14] were
synthesized by Dharmacon (Lafayette, CO) and transfected according
to the manufacturer's protocol. Cathepsin D gene construct (Origen,
Rockville, MD) was transfected using lipofectamin as described by the
manufacturer. Twenty four hours after transfection, the cells were
treated with iCL and maintained in culture for an additional 48 h
before measure of cell viability and expression of the silenced
molecules by Western blot.
3. Results
3.1. Analysis of proteolytic reactions between cathepsin L, cathepsin D
and caspase-3 in vitro
Active forms of the enzymes were incubated in their correspon-
ding reaction buffers with the remaining enzymes used as potential
substrates and at the end of the proteolysis reaction, Western blots
using speciﬁc antibodies were carried out to assess the extent of
cleavage. As shown in Fig. 1 (panel A), incubation of cathepsin L with
either cathepsin D or caspase-3 resulted in a sharp decrease in the
amount of the latter two enzymes while the level of cathepsin L itself
was not affected. This data suggests that cathepsin L was able to
Fig.1. Proteolytic interactions between cathepsin L (CL), cathepsin D (CD) and caspase-3 (C-3). Recombinant cathepsin L (panel A), cathepsin D (panel B) and caspase-3 (panel C) were
respectively incubated in the corresponding buffers under optimal conditions with each one of the remaining enzymes used as substrates. At the end of reaction, protein mixtures
were separated by electrophoresis and individual enzymes detected with speciﬁc antibodies. The activity of individual enzymes, cathepsin L (CL, panel D), cathepsin D (CD, panel E)
and caspase-3 (C-3, panel F), were measured in vitro at the end of reactions described in panel A. Protease activities are represented in arbitrary units (AU). The data represent means
of three determinations±SE.
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Of note, cathepsin D was able to degrade caspase 3 in cathepsin L
reaction buffer however caspase-3 was unable to cleave any of the
cathepsins under these conditions. In agreement with these proteo-
lytic reactions, respective enzyme activities (Fig. 1, panels D–F)
correlated with the protein levels detected in panel A, indicating
that proteolysis of any of these enzymes is likely to translate into loss
of activity.
When experiments similar to those described in Fig. 1 (panel A)
were carried out under optimal conditions for cathepsin D (Fig. 1,
panel B), caspase-3 was degraded by both cathepsins, however, none
of these enzymes was hydrolyzed suggesting that they may have
superior proteolytic capability than caspase-3. This is conﬁrmed by
the ﬁnding that caspase-3, even under conditions optimum for its
activation, was unable to degrade cathepsin L or D as shown in Fig. 1
(panel C). Similar experiments to those described in panel D, E and F
regarding the correlation between protein amounts, detected by
Western blot in panel B and panel C, and the corresponding enzymatic
activities were carried out and the results conﬁrmed this correlation
(data not shown). Together, the data presented in Fig. 1 suggest that
cathepsin L is the strongest among the three proteases tested,therefore, its targeting is likely to inﬂuence intracellular levels of
caspase-3 and susceptibility apoptosis.
3.2. Characterization of cellular response associated with
cathepsin L inhibition
Taking into account the demonstrated role of cathepsin L in cell
survival [13], the data described above (Fig. 1) suggests that speciﬁc
inhibition of this enzyme may result a cell death characterized by
increased accumulation of cathepsin D and decreased caspase-3. To
verify this hypothesis, we analyzed the cellular toxic response caused
by incubation with increasing amounts of cathepsin L inhibitor (iCL).
As shown in Fig. 2A, this compound induced a dose dependent
suppression of SaOS2 cell proliferation with a maximum effect at
40 μM. Morphologically, only small changes were noticed at low and
intermediate drug concentrations (10 and 20 μM). However when
cells were treated with 40 μM, cytoplasmic vacuoles were formed and
the cells become round before undergoing death (Fig. 2B). Electron
microscopy revealed noticeable changes particularly in the cytoplasm
of cells treated with iCL at 40 μM. The most obvious changes were
extensive vacuolization and the presence of double membrane
Fig. 2. Cellular response to cathepsin L inhibition. (Panel A) SaOS2 cells were incubated in 24 well plates with increasing concentrations of cathepsin L inhibitor (μM) and cell number
counted for up to 6 days. (Panel B) Morphological changes associated with iCL treatment. (Panel C) Ultra-structural modiﬁcations induced by iCL at the cellular level. Note that at
40 μM, iCL induced cytoplasmic vacuolization and the appearance of double membrane vesicles containing undigested material indicative of autophagic death (ctl: control., Cyto:
cytoplasm., pm: plasma membrane). (Panel D) SaOS-2 cells were treated with iCL (40 μM) in the absence or the presence of 3-MA for 24 h. LC3-II staining was detected by
ﬂuorescence microscopy. A representative staining from three independent experiments is shown. (Panel E) SaOS2 cells were treated as in panel D with iCL for 24 h, then ﬁxed and
analysed by ﬂow cytometry to measure apoptosis. (P.C: positive control where the cells were exposed to doxorubicin 10−6 M for 24 h).
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additionto this, ﬂuorescence microscopy (Fig. 2D) demonstrated
increased amounts of the autophagic marker LC3-II in cells treated
by 40 μM of iCL, and that expression of this marker was suppressed by
the autophagosome inhibitor 3-MA (Fig. 2D). Flow cytometry analysis
indicated that cathepsin L inhibitor at 40 μM did not induce apoptotic
death (Fig. 2E). Together, these features are reminiscent of autophagic
cell death [15–17].
3.3. Molecular determinants associated with cellular response to
cathepsin L inhibition
We have analyzed the expression of molecular markers known to
be associated with autophagy such as cathepsin D, the mannose
6-phosphate receptor (MPR) and LC3-II [15,18] and compared their
expression to that of the cell cycle inhibitor p21/WAF1, a marker of
proliferation arrest [19], and also to that of caspase-3 activation.
As shown in Fig. 3A, exposure to low concentrations of iCL was
associated with an increased expression of p21/WAF1 in agreement
with our previous ﬁndings that inhibition of cathepsin L [13] forces
cancer cells into senescence. Cathepsin D expression increased in a
dose dependent manner and particularly in response to high
concentrations of iCL, conﬁrming the observation made earlier thatthis enzyme could be a substrate for cathepsin L in vivo. Expression
of MPR also increased in a manner that correlates cathepsin D,
reaching a maximum at 40 μM of iCL, and thus seems to correlate
with the onset of autophagy observed in Fig. 2B–D. Moreover, the
light chain of LC3 (LC3-II) accumulated at this iCL concentration
(Fig. 3A), further conﬁrming the autophagic nature of this cellular
response.
Analysis of caspase-3 cleavage in cells treated with iCL (Fig. 3B) led
to the unexpected ﬁnding that at (40 μM), this compound caused a
unique proteolytic proﬁle of this enzyme with the appearance of a
band at about 25 KD termed CLIF (for Cathepsin L inhibition-Induced
Fragment). As shown in this ﬁgure, the p19 and p17 fragments that are
usually generated in response to apoptosis-inducing stressors such as
doxorubicin, represent minor fractions of the total cleavage products
in response to cathepsin L inhibition. This data suggests that apoptosis
may represent only a minor component of cell death induced by
cathepsin L inhibitor and that autophagy may indeed be the dominant
response to this treatment.
The role of CLIF in mediating autophagy in this system is not yet
clear, however, we found that in cells treated with doxorubicin to
activate caspase-3, cathepsin L inhibition reduced the level of the
active enzyme and enhanced the levels of CLIF in a dose dependent
manner (Fig. 3C). Since this appeared to correlate with expression
Fig. 3. Molecular determinants associated with cathepsin L inhibition. (Panel A) Cells
were treated with increasing iCL concentrations for 24 h and expression of p21/WAF1,
cathepsin D (CD), Manose-6-phosphate receptor (MPR) and LC3-II (arrow) was detected
by Western blot using speciﬁc antibodies. Antibody to β-actin was used as a loading
control. (Panel B) SaOS2 cells were treated with doxorubicin (10−6 M) or with iCL at the
indicated concentrations for 24 h and the proteolytic cleavage of pro-caspase-3 (Pro-C3)
into the cells was analyzed byWestern blot. Antibody to beta actin (β-actin) was used as
a loading control. CLIF (Cathepsin L Inhibition-induced Fragment). (Panel C) Analysis of
iCL induction of CLIF: SaOS2 cells were treated with doxorubicin 10−6M in the absence
or the presence of iCL at 20 or 40 μM. After incubation for 24 h,Western blot was carried
out to analyze expression of active caspase-3 (fragments p17 and p19) and CLIF.
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represent a product of degradation of caspase-3 by cathepsin D.
3.4. Respective roles of cathepsin L and D in mediating cellular response
to iCL
To determine whether cellular response to iCL was indeed caused
by speciﬁc inhibition of cathepsin L, we transfected cells with siRNA
oligonucleotides to knockdown expression of this enzyme, and
analyzed expression of the molecular markers associated with
proliferation arrest, autophagy and apoptosis. We have found thatincreased amounts of cathepsin L siRNA inhibited cellular prolifera-
tion in a dose dependentmanner (Supplemental data S1), highlighting
the essential role of this enzyme in cellular protection. Also, in a
manner that was inversely proportional to decreased cathepsin L
expression (Fig. 4A), those of p21/WAF1 and cathepsin D increased.
Interestingly, no caspase-3 activation or DNA fragmentation were
detected under these conditions (Fig. 4A and Supplemental data S1),
conﬁrming the ﬁndings described above that a loss of cathepsin L
function may cause a non-apoptotic cell death. Morphological and
immunostaining analyses further conﬁrmed that siRNA to cathepsin L
induces autophagy as the transfected cells displayed increased
vacuolization and LC3-II staining (Fig. 4B).
The role of cathepsin D inmediating iCL-induced autophagy and its
association with CLIF were investigated by inducing gain and loss of
expression of this enzyme. As shown in (Fig. 4C), cathepsin D gene-
tranfected cells had elevated amounts of the enzyme as compared to
non-transfected cells or those transfected with the empty plasmid. As
it would be expected, iCL induced the expression of cathepsin D in the
non-transfected cells, and to a much stronger extent in the transfected
ones (Fig. 4C). Cellular vacuolization was also enhanced in cathepsin
D-transfected cells in the presence and in the absence of iCL (Fig. 4D).
We have noted that when cells were treated with 40 μM iCL, they
become round and detach, rendering pictures difﬁcult to take (data
not shown). Inversely, iCL-induced cathepsin D expression was
completely suppressed in cells transfected with the corresponding
siRNA (Fig. 4E). This was associated with reduced vacuolization
induced by iCL (Fig. 4F). Interestingly, CLIF was also associated with
the induction of cathepsin D and the onset of autophagy (Fig. 4C–F)
suggesting that expression of this caspase-3 isoform is directly related
to cathepsin D and that the two molecules may play key roles in
mediating the autophagic effect of iCL.
In summary, our data suggests that cathepsin L may exert its pro-
survival function by degrading the pro-death proteases cathepsin D
and caspase 3. We also show that inhibition of cathepsin L does not
necessarily enhance cellular susceptible to apoptosis, particularly in
cells that express cathepsin D. While moderate inhibition of cathepsin
L enhanced expression of the cell cycle inhibitor p21/WAF1 resulting
in proliferation arrest, severe inhibition of this enzyme resulted in
enhanced accumulation of cathepsin D and depletion of cellular pools
of caspase 3, thereby causing a switch from apoptosis to autophagy.
Based on this, it is suggested that depending on cathepsin L inhibition
level, cancer cell may undergo either proliferation arrest or autophagic
cell death. This later demise appears, at least in our cellular models, to
be associated with the accumulation of cathepsin D and CLIF.
4. Discussion
For more than a decade, apoptosis has taken the central stage as
the most relevant biological response of cancer cells to a variety of
treatments, consequently, elements of the associated pathways were
often utilized for a rational design of new anti-cancer therapeutics.
However not all cancer cells are susceptible to apoptosis and evidence
is now accumulating that in response to chemotherapeutic agents,
they may activate alternative pathways leading either to irreversible
growth arrest (senescence) or non-apoptotic types of cell death such
as necrosis, mitotic catastrophe, and autophagy [20,21]. Moreover, it
has been demonstrated that inhibition of apoptosis may result in a
switch to senescence, necrosis or other undeﬁned cell deaths [22–24],
highlighting the need for identiﬁcation of molecular mechanisms that
regulate these switches. The present study investigated the existence
of a proteolytic hierarchy between pro-survival and pro-death
proteases, and its role in regulating cellular decisions between
survival, apoptosis and autophagy. This was addressed by measuring
the ability of caspase-3 (implicated in apoptosis), cathepsin D
(implicated in both apoptosis and autophagy), or cathepsin L
(implicated in cell survival) to neutralize the other two proteases,
Fig. 4. Respective roles of cathepsin L and cathepsin D in mediating cellular response to iCL. (Panel A) SaOS2 cells were non-transfected (Ctl), treated with the transfection reagent
alone (TR), or transfected with increasing amounts of siRNA to cathepsin L (CLsiRNA). Expression of cathepsin L and other molecular markers of proliferation arrest (p21/WAF1),
apoptosis (active caspase-3, Act. C-3), and autophagy (cathepsin D, CD) were analyzed in siRNA-transfected and non-transfected cells by Western blot using speciﬁc antibodies.
Positive control (PC) represents SKN-SH cells treated with doxorubicin 10−6 M for 24 h. (Panel B) The cells were treated as above (panel B) and cellular morphology was analyzed
underlight microscopy to detect vacuols (upper panel). Staining for LC3-II was visualized by confocal microscopy. (Panel C) SaOS2 cells non-transfected (Ctl) transfected with the
empty vector alone (V) or with the vector containing cathepsin D construct (V-CD) were analyzed byWestern blot for expression of this enzyme in the presence or the absence of iCL
(20 μM) as described above. Expression of CLIF was also analyzed under these conditions. Antibody to β-actin was used as a loading control. (Panel D) Light microscopy photographs
showing cellular vacuolization in cells transfectedwith the vector alone (V) or with the vector harboring cathepsin D construct (V-CD) in the absence or in the presence of iCL (20 μM).
(Panel E) effect of siRNA to cathepsin D on expression of the enzyme and that of CLIF. SaOS2 cells were transfected wither with a vehicle transfection reagent alone (TR) or siRNA to
cathepsin D (CD-si). Expression of both cathepsin D and CLIF were analysed byWestern blot. Antibody to beta actin (β-Actin) was used as a loading control. (Panel F) Light microscopy
photographs showing cellular vacuolization in cells non-transfected (Ctl), transfected with the reagent alone (TR) or with the reagent containing cathepsin D siRNA (CD-si) and this in
the absence or in the presence of iCL (40 μM).
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death. The data shown in Fig. 1 provided evidence in support of this
concept and suggested that the pro-survival, cathepsin L, located at
the top of this proteolytic cascade, is likely to play a key role in
regulating the levels of cathepsin D and caspase-3 as well as the
cellular processes associated with them.
The protease cascade described here also provided further support
for the pro-survival function of cathepsin L and suggest that this may
be due, at least in part, to its ability to deplete the cells from the pro-
apoptotic molecule caspase-3. However, since cathepsin L inhibition
causes the accumulation of cathepsin D (a caspase-3 hydrolase), the
ensuing death would be associated with cathepsin D and not with
caspase 3. The data shown in Fig. 2 are in support of this hypothesis as
cellular treatment with increasing amounts of iCL culminated in
induction of autophay. Expression of several morphological and
molecular markers indeed conﬁrmed this observation. These include
increased cellular vacuolization (Fig. 2B), the accumulation of
autophagosomes (Fig. 2C), LC3-II staining and its inhibition by 3-MA
(Fig. 2D), and the absence of apoptotic death (Fig. 2E). Also, Western
blot analysis of cells subjected to treatment with increased concen-tration of cathepsin L inhibitor induced a number of molecular
autophagic markers (Fig. 3A), providing further evidence that
autophagy is the primary type of death induced by this approach.
Curiously, the lack of caspase-3 activation is compensated for by the
appearance of high molecular weight isoform of this enzyme (CLIF),
that correlated with the level of cathepsin D expression in iCL treated
cells (Figs. 3C, 4C and E). The actual role of CLIF as a mediator of
autophagic death or as a cellular marker of this cellular demise
remains to be elucidated.
The speciﬁcity of cathepsin L inhibition in triggering autophagywas
veriﬁed by inhibiting its expressionwith siRNAs (Fig. 4),which resulted
in enhanced accumulation of molecular determinants associated with
this cell death (i.e. cathepsin D and LC3-II) in the transfected cells.
These ﬁndings (Fig. 4A) further conﬁrmed the observation made
earlier that caspase-3was not activated by such treatment and that the
cells may have died primarily from autophagy. We speculate that the
lack of caspase-3 activation in response to cathepsin L inhibition may
be caused by increased degradation bycathepsinD, suggesting that the
latter enzyme could be responsible for switching cell death from
apoptosis to autophagy. The results presented in Fig. 4C–F are in favor
2300 X. Zheng et al. / Biochimica et Biophysica Acta 1783 (2008) 2294–2300of this possibility since genetic manipulations leading to either loss or
gain of cathepsin D function affected cellular ability to undergo
autophagy. Based on this, cathepsin D may represent a conceivable
target to manipulate cellular decision to undergo autophagy.
In conclusion, the present study provided evidence for the
existence of a proteolytic hierarchy between pro-survival and pro-
death proteases and suggested that changes in cellular proteolytic
proﬁles are likely to have signiﬁcant consequences not only on its
survival but also on the type of death it may undergo in response to a
speciﬁc stress. Comprehensive investigation of cellular protease
signature and proteolytic hierarchy is warranted as this may open
new avenues for the design of approaches to better control cellular
fate in normal and diseased tissues.
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